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Dendritic cells (DCs) are specialized antigen-presenting cells that regulate both immunity
and tolerance. DCs in the periphery play a key role in expanding naturally occurring Foxp3+
CD25+ CD4+ regulatory T cells (Natural T-regs) and inducing Foxp3 expression (Induced
T-regs) in Foxp3− CD4+ T cells. DCs are phenotypically and functionally heterogeneous,
and further classified into several subsets depending on distinct marker expression and
their location. Recent findings indicate the presence of specialized DC subsets that act to
expand Natural T-regs or induce Foxp3+ T-regs from Foxp3− CD4+ T cells. For example,
two major subsets of DCs in lymphoid organs act differentially in inducing Foxp3+ T-regs
from Foxp3− cells or expanding NaturalT-regs with model-antigen delivery by anti-DC sub-
set monoclonal antibodies in vivo. Furthermore, DCs expressing CD103 in the intestine
induce Foxp3+ T-regs from Foxp3− CD4+ T cells with endogenous TGF-β and retinoic acid.
In addition, antigen-presenting DCs have a capacity to generate Foxp3+ T-regs in the oral
cavity where many antigens and commensals exist, similar to intestine and skin. In skin
and skin-draining lymph nodes, at least six DC subsets have been identified, suggesting a
complex DC-T-reg network. Here, we will review the specific activity of DCs in expanding
NaturalT-regs and inducing Foxp3+ T-regs from Foxp3− precursors, and further discuss the
critical function of DCs in maintaining tolerance at various locations including skin and oral
cavity.
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INTRODUCTION
Ralph Steinman and Zanvil Cohn discovered dendritic cells (DCs)
in 1973. DCs have been shown to play a key role in the immune
system to link innate and adaptive immunity (Steinman, 2012),
a finding that won the Nobel Prize in 2011. DCs not only acti-
vate the immune system, but also participate in maintaining
immunological-self tolerance (Steinman et al., 2003). DCs in the
periphery actively induce tolerance when self-antigens are pre-
sented in the steady state (Hawiger et al., 2001; Bonifaz et al.,
2002). In addition, DCs are critical antigen-presenting cells to
regulate Foxp3+CD25+CD4+ regulatory T cells (T-regs) in the
periphery (Yamazaki et al., 2006a; Yamazaki and Steinman, 2009).
T-regs are currently divided into thymic-derived Natural T-regs
and peripheral Induced T-regs (Abbas et al., 2013). Recent find-
ings have shown that Natural T-regs and Induced T-regs may be
functionally and epigenetically different (Josefowicz et al., 2012;
Ohkura et al., 2012; Samstein et al., 2012). The recent proposal of
the nomenclature for T-regs recommends that “tT-reg (thymus-
derived T-reg)”and“pT-reg (peripheral induced T-reg)”should be
used instead of Natural T-regs and Induced T-regs (Abbas et al.,
2013). The title of the Research Topics of Frontier Immunology is
“Natural T-reg vs. Induced T-reg,” therefore, we use the term “Nat-
ural T-reg” and “Induced T-reg” in this review. The two types of
T-regs appear indistinguishable on the surface, but the expression
of Neuropilin can distinguish Natural T-regs and Induced T-regs
in mice but not in humans (Milpied et al., 2009; Weiss et al., 2012;
Yadav et al., 2012). Helios may be another marker for thymic-
derived T-regs (Thornton et al., 2010), but can be expressed
on Induced T-regs in some conditions (Akimova et al., 2011;
Gottschalk et al., 2012). In most literature, Natural T-regs may
be the mixture of thymic-derived T-regs and peripheral induced
T-reg because the T-regs were purified from spleen and lymph
nodes, and Helios and Neuropilin were not investigated. If CD4+
transgenic mice with RAG−/− background such as OT II RAG−/−
mice are used in the literature, the T-regs should be peripheral
induced T-regs because those mice lack Foxp3+ T-regs (Itoh et al.,
1999).
In the current review, we have focused on the roles of DCs in
expanding antigen-specific Natural T-regs and inducing antigen-
specific Foxp3+ T-regs (Induced T-regs) from Foxp3− CD4+
T cells. Recent studies indicate that DCs in different location
have distinct subsets for expanding Natural T-regs and generating
Induced T-regs.
THYMIC-DERIVED NATURAL T-REGS ARE ANERGIC, BUT CAN
BE EXPANDED BY ANTIGEN-PRESENTING DCs
Sakaguchi et al. (1995) investigated autoimmune diseases induced
by neonatal thymectomy, and discovered that a subpopulation
of peripheral CD4+ T cells that express IL-2 receptor-α (CD25)
derived from the thymus play a regulatory role in maintaining
immunological-self tolerance (Asano et al., 1996). Their striking
finding was that CD25+CD4+ regulatory T cells exist in normal
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naïve CD4+ T cell population in the periphery with no immuniza-
tion in mice. Subsequently, the groups of Shevach and Sakaguchi
simultaneously reported one of the most prominent characteris-
tics of CD25+CD4+ T-regs, specifically,“ CD25+CD4+ T-regs are
anergic and suppressive upon T cell-receptor (TCR) stimulation
with splenic antigen-presenting cells in vitro” (Takahashi et al.,
1998; Thornton and Shevach, 1998). Thymic CD25+CD4+CD8−
T cells were additionally shown to be anergic and suppressive
(Itoh et al., 1999). Therefore, at that time, thymic-derived Natural
T-regs were considered non-proliferative and tough to expand,
which posed a major limitation, as considerable numbers of
CD25+CD4+ T-regs are required to develop new treatments for
autoimmunity.
Subsequently, we and others showed that CD25+CD4+ Nat-
ural T-regs can be expanded, even without exogenous IL-2, when
DCs are used as antigen-presenting cells (Yamazaki et al., 2003;
Fehervari and Sakaguchi, 2004). According to the recent pro-
posal of the nomenclature for T-regs (Abbas et al., 2013), these
CD25+CD4+ T-regs that we used in our experiments may be
mixture of thymic-derived T-regs and peripheral induced T-
reg. Both CD25+CD4+ T-regs in the periphery and thymic
CD25+CD4+CD8− T cells produced a small amount of IL-2 fol-
lowing stimulation with antigen-presenting DCs (Yamazaki et al.,
2003; Fehervari and Sakaguchi, 2004). Moreover, expansion of
CD25+CD4+ T-regs was partially dependent on the expression
of CD86 and CD80 on DCs and IL-2 (Yamazaki et al., 2003).
IL-2 is important for T-reg function and survival (Malek et al.,
2002; Bayer et al., 2005; Setoguchi et al., 2005). Importantly, fur-
ther investigations showed that the expanded Natural T-regs by
antigen-presenting DCs suppress type-1 diabetes in NOD mice
(Tarbell et al., 2004) and graft-versus-host diseases (GVHD) in an
antigen-specific manner (Yamazaki et al., 2006b).
POSSIBLE ROLE OF MONOCYTE-DERIVED DCs IN
EXPANDING NATURAL T-REGS DURING INFLAMMATION
Examination of several types of antigen-presenting cells, including
resident classical DCs, for Natural T-reg expansion ability, revealed
that lipopolysaccharide (LPS)-stimulated mature bone-marrow-
derived DCs (BM-DCs) and lymph node DCs from complete
Freund’s adjuvant (CFA)-treated mice exhibit the highest Natural
T-reg expansion activity (Yamazaki et al., 2003).
Recent studies demonstrated that DC-SIGN/CD209a+
monocyte-derived DCs are recruited upon LPS injection, and
accumulated in the T cell area of skin-draining lymph nodes
(Cheong et al., 2010). DC-SIGN/CD209a+ monocyte-derived
DCs were as functionally active as resident classical DCs when
tested for capture of antigen and presentation ability to MHC
class I and class II to stimulate effector T cells. Specifically, DC-
SIGN/CD209a+ cells were recruited from blood monocytes in a
toll-like receptor (TLR)-4-, CD14-, and TRIF-dependent manner
(Cheong et al., 2010). CFA contains mycobacterium tuberculosis,
which can stimulate TLR-4 (Kleinnijenhuis et al., 2011).
We propose that DC-SIGN/CD209a+ monocyte-derived DCs
expand not only effector T cells, but also Natural T-regs for
the regulation of inflammation (Figure 1). This would indicate
that inflammation induced by microbe signals induces DC mat-
uration and activates effector cells, but simultaneously induces
Natural T-reg expansion to control the inflammatory process
(Figure 1). While inflammation is induced by several stimuli, it
remains to be established whether other stimuli except TLR-4 can
generate DC-SIGN/CD209a+monocyte-derived DCs in vivo. Fur-
ther studies are necessary to investigate the signals that recruit
DC-SIGN/CD209a+ monocyte-derived DCs.
The finding that Natural T-regs can be expanded by mature
DCs during inflammation is intriguing. The next issue to resolve
is whether Induced T-regs are also generated during inflammation
that have a role in controlling the inflammatory process. As we dis-
cussed below, Induced T-regs are generated via signaling through
TGF-β LPS-matured BM-DCs are active in inducing Foxp3+ T-
regs from Foxp3− CD4+ T cells in the presence of active TGF-β
(Yamazaki et al., 2007). TGF-β is produced as an inactive latent
complex from many cells, and activation is localized to sites where
TGF-β is released from latency (Li and Flavell, 2008; Yang et al.,
2012). TGF-β has been shown to be activated by αvβ8 integrin on
the DC surface (Travis et al., 2007). Therefore, it is possible that
Induced T-regs are generated by mature DCs that participate in
controlling the inflammation as well as Natural T-regs, as long as
TGF-β is provided from other cells (Figure 1).
DCs ARE PROFESSIONAL ANTIGEN-PRESENTING CELLS
THAT INDUCE FOXP3 EXPRESSION FROM FOXP3− CD4+ T
CELLS IN THE PRESENCE OF TGF-β
Foxp3 is an established critical transcription factor for T-reg devel-
opment and function (Fontenot et al., 2003; Hori et al., 2003;
Khattri et al., 2003). In addition to thymic-derived Natural Foxp3+
T-regs, Foxp3+ T-regs are induced from Foxp3− CD4+ T cells
in the periphery, designated “Induced T-regs,” “Adaptive T-regs,”
or pT-regs (Abbas et al., 2013). The finding that Foxp3+ T-regs
are induced from Foxp3−CD25−CD4+ T cells with TGF-β in the
periphery was initially reported by Chen et al. (2003).
To investigate whether DCs play a role in the induction of
Foxp3+ T-regs from Foxp3− CD4+ T precursors, using OVA
CD4+ T-cell-receptor transgenic mice with RAG−/− background,
we compared the Foxp3 induction activities of spleen CD11c+DCs
with DC-depleted splenocytes (Yamazaki et al., 2007). Notably,
lower numbers of DCs were able to induce more Foxp3+ T-regs
with smaller doses of peptide antigens in the presence of TGF-β
(Yamazaki et al., 2007). The T-regs induced by antigen-presenting
DCs were suppressive in vitro and in vivo (Yamazaki et al., 2007).
DCs were also able to induce Foxp3+ T-reg from wild-type poly-
clonal Foxp3−CD4+ T precursors via allogeneic mixed leukocyte
reactions. Allogeneic DCs expand functional Induced Foxp3+
T-regs in the presence of with TGF-β in vitro (unpublished data).
The collective findings indicate that DCs require only a small
amount of antigen to induce Foxp3+ T-regs if TGF-β is provided
from the environment, supporting the theory that DCs are the pro-
fessional antigen-presenting cells to induce Foxp3+ T-regs from
Foxp3− precursors in the periphery.
THE FOXP3+ T-REG NUMBER IS REGULATED BY DCs IN VIVO
In keeping with the above findings that DCs expand Natural T-
regs and induce T-regs from Foxp3− T cells, the numbers of DCs,
and Foxp3+ T-regs in vivo correlate with each other. GM-CSF,
a key cytokine in DC generation (Caux et al., 1992; Inaba et al.,
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FIGURE 1 | Monocyte-derived DCs expand Foxp3+ T-regs to control
inflammation. DC-SIGN/CD209a+ monocyte-derived DCs are recruited to
the site of inflammation by TLR-4 ligands such as LPS or CFA. The mature
monocyte-derived DCs present antigens to not only effector T cells but also
Natural T-regs. LPS-matured DCs can expand functional Natural T-regs
(Yamazaki et al., 2003). If TGF-β is provided from other cells, mature DCs in
the inflammatory site can stimulate the generation of Induced T-regs from
Foxp3− CD4+ T cells in the presence of antigen (Yamazaki et al., 2007).
Expanded Natural T-regs and Induced T-regs may play a role in controlling
inflammation.
1992; van de Laar et al., 2012), was shown to promote Natural
T-reg expansion via DC generation and prevent type 1 diabetes in
NOD mice (Gaudreau et al., 2007). Similarly, repetitive injection
of Fms-like tyrosine kinase 3 ligand (FLT3L), another important
cytokine for DC development (Maraskovsky et al., 1996; Waskow
et al., 2008), induced expansion of Natural T-regs (Swee et al.,
2009). Moreover, in vivo ablation of Foxp3+ T-regs in Foxp3-
diphtheria toxin (DT) receptor (Foxp3-DTR) mice led to increased
DC number in vivo (Kim et al., 2007). Division of DC precursors
is controlled by Foxp3+ T-regs (Liu et al., 2009), and the num-
bers of DCs are directly correlated with the Foxp3+ T-reg number
in vivo (Darrasse-Jeze et al., 2009). Notably, Foxp3+ T-reg number
was reduced in CD11c-DT receptor (CD11c-DTR) bone marrow
chimera mice after depletion of CD11c+DCs (Darrasse-Jeze et al.,
2009). Therefore, Foxp3+ T-regs and DCs appear to regulate each
other in vivo.
However, constitutive DC-depleted mice contain normal level
of Foxp3+ T-regs in the thymus and periphery (Birnberg et al.,
2008; Ohnmacht et al., 2009). Birnberg et al. (2008) crossed
CD11c-Cre BAC transgenic mice with those harboring a condi-
tional diphtheria toxin A (DTA) transgene in the constitutively
active Rosa26 locus (CD11c-DTA mice). CD11c-DTA mice con-
stitutively lacked classical DCs, but contained spared amount of
plasmacytoid DCs (pDCs) and epidermal Langerhans’ cells (LCs).
These mice developed myeloproliferative diseases, but contained
normal Foxp3+ T-reg numbers in thymus and spleen (Birnberg
et al., 2008). Foxp3+ T-regs from CD11c-DTA mice constitutively
lacking classical DCs exerted suppressive effects in vitro (Birn-
berg et al., 2008). Subsequently, Ohnmacht et al. (2009) developed
similar CD11c-DTA mice with constitutive loss of all classical
DCs, pDCs, and LCs. In their mice, both intrathymic Natural
T-reg development and peripheral Foxp3+ T-reg induction were
normal, but Th1 and Th17 cells were spontaneously increased
(Ohnmacht et al., 2009).
Thus, there is a discrepancy in the number of Foxp3+ T-
regs between CD11c-DT receptor (CD11c-DTR) bone marrow
chimera mice (Darrasse-Jeze et al., 2009) and constitutive DC-
depleted mice (Birnberg et al., 2008; Ohnmacht et al., 2009), in
which may be attributed to the differences between acute and
chronic DC depletion. In the case of acute DC depletion with DT,
DC activity in maintaining Foxp3+ T-regs may be easy to detect.
In contrast, upon constitutive deletion of DCs, antigen-presenting
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cells other than DC may be able to compensate and rescue the
development and homeostasis of Foxp3+ T-regs in the periphery.
Alternatively, in the case of Birngerb’s mice, it is possible that pDCs
and LCs are sufficiently active in maintaining the Foxp3+ T-regs
in the periphery.
Taken together, the results indicate that DCs regulate the num-
bers of Foxp3+ T-regs in vivo. It is possible that DCs regulate
the numbers of Foxp3+ T-regs in vivo may be dependent on IL-
2, which is an important cytokine both for Natural T-regs and
Induced T-regs (Malek et al., 2002; Bayer et al., 2005; Setoguchi
et al., 2005; Davidson et al., 2007). DCs has been shown to pro-
duce IL-2 upon LPS stimulation (Granucci et al., 2001). Treatment
of anti-IL-2 antibody reduces the numbers of T-regs in vivo and
main source of IL-2 was T cells (Setoguchi et al., 2005). How-
ever, we cannot deny the possibility that IL-2 from DCs have a
role in regulating the numbers of Foxp3+ T-regs especially in the
inflammatory condition.
The types of T-reg (Natural or Induced) regulated by DCs
in vivo were the next focus of discussion. In FLT3-treated mice,
adoptively transferred Foxp3+ T cells were expanded, but not con-
verted into Foxp3+ T-regs (Darrasse-Jeze et al., 2009; Swee et al.,
2009). Thymectomy prior to FLT-3 treatment did not affect the
observed increase of Foxp3+ T-regs. Accordingly, it is suggested
that the thymic output of Foxp3+ T-reg does not contribute to
the increase of T-reg by FLT-3 (Swee et al., 2009). GM-CSF treat-
ment induced expansion of Natural T-regs, but no conversion of
Foxp3− T cells into Foxp3+ T-regs in vitro (Zou et al., 2010). It
appears that DCs expanded by FLT-3 or GM-CSF in vivo regulate
Natural, rather than Induced T-regs.
In experiments where polyclonal Foxp3−CD4+ T cells were
used for the adoptive transfer in these reports, no cognate antigen
was employed (Darrasse-Jeze et al., 2009; Swee et al., 2009; Zou
et al., 2010). TCR repertoires from Natural T-regs are reported
to be more skewed to self antigens (Jordan et al., 2001; Hsieh
et al., 2004, 2006; Sakaguchi et al., 2008). Therefore, it is pos-
sible that TCR stimulation was insufficient to induce Foxp3 in
adoptive transferred Foxp3− CD4+ T cells from wild-type poly-
clonal mice in these reports. Peripheral induction of Foxp3 appears
to favor suboptimal TCR stimulation (Kretschmer et al., 2005;
Gottschalk et al., 2010), however, TCR stimulation is required for
induction of Foxp3 (Ohkura et al., 2012). Therefore, we cannot
discount the possibility that the Induced Foxp3+ T-regs are reg-
ulated by DCs in vivo. For example, en earlier study by Huang
et al. (2010) showed that in vivo injection of IL-10-treated BM-
DCs promoted the conversion of Foxp3−CD25−CD4+ T cells into
Foxp3+CD25+CD4+ T-regs and prevents asthma attack. In this
case, IL-10-treated BM-DCs may regulate Induced Foxp3+ T-regs.
SPECIALIZED DC SUBSETS MAY EXPAND NATURAL T-REGS
AND INDUCED T-REGS
The next issue addressed is identifying the DC subsets that regulate
Foxp3+ T-regs in vivo. DCs constitute several subsets with dis-
tinct functions (Heath and Carbone, 2009; Hashimoto et al., 2011;
Belz and Nutt, 2012; Steinman, 2012). Murine classical spleen
DCs are divided into two major subsets, i.e., CD8+DEC205+
and CD8−DCIR2+ (Dudziak et al., 2007). Accumulating evi-
dence indicates that antigen delivery to CD8+DEC205 DCs by
anti-DEC205 monoclonal antibody induces Foxp3+ T-regs from
Foxp3− T cells in vivo (Mahnke et al., 2003; Kretschmer et al., 2005;
Yamazaki et al., 2008). Moreover, Natural T-regs are expanded by
CD8− DCIR2+ DCs via model-antigen delivery by anti-DCIR2
monoclonal antibody in vivo (Yamazaki et al., 2008).
TGF-β plays an important role in the mechanisms of induction
of Foxp3+ T-regs from Foxp3−T precursors via in vivo antigen
targeting to DCs (Kretschmer et al., 2005). When the protein
level of TGF-β production was compared, DEC205+CD8+DCs
produced more TGF-β than CD8−DCIR2+ DCs in the steady
state (Yamazaki et al., 2008). DEC205+CD8+DCs induced Foxp3+
T-regs from Foxp3−CD4+ T cells without exogenous TGF-
β. The induction of Foxp3+ T-regs by DEC205+CD8+DCs
was blocked by anti-TGF-β neutralizing antibody. Importantly,
DEC205+CD8+DCs matured with poly:IC, a TLR-3 ligand, pro-
duced less TGF-β than immature DEC205+CD8+DCs DCs from
steady state (Yamazaki et al., 2008). CD8−DCIR2+ DCs were more
potent inducers of Foxp3+ T-regs after addition of TGF-β into
the culture, indicating that CD8−DCIR2+ DCs can use TGF-β
provided from other cells (Yamazaki et al., 2008) (Table 1).
Recent studies in DEC205 conditional knockout mice (DEC205
Dt/DT) (Fukaya et al., 2012) support the findings that
DEC205+CD8+DCs induce Foxp3+ T-regs from Foxp3− cells and
CD8− DCIR2+ DCs expand existing Natural T-regs (Yamazaki
et al., 2008). Fukaya et al. (2012) used bone marrow chimeric
mice reconstituted with bone marrow from DEC205 Dt/DT mice,
lacking DEC205+CD8+DCs via DT injection. DEC205+DCs were
depleted for about 7 days after DT injection,with a complementary
increase in CD8− DCs. In DEC205+DC-depleted mice, peripheral
Foxp3+ T-reg numbers were increased, suggesting that existing
Natural T-regs in the periphery are expanded by complemen-
tally increased CD8− DCs. Upon transfer of Foxp3− CD4+ OVA
transgenic OT II T cells into the chimeric DEC205+DC-depleted
mice, antigen-specific induction of Foxp3+ T-regs from Foxp3−
CD4+ T cells was impaired (Fukaya et al., 2012). Therefore,
DEC205+CD8+ DCs appear critical for the induction of Foxp3+
T-regs from Foxp3− CD4+ T cells in the periphery. Notably,
epidermal host-derived LCs remained in chimeric DEC205+
Table 1 | Foxp3+ T-regs and classical spleen DCs in the steady state.
CD8+DEC205+ DCs CD8−DCIR2+ DCs Reference
In vivo OVA targeting Induce T-regs Expand natural T-regs Yamazaki et al. (2008)
TGF-β production High in steady state Low Yamazaki et al. (2008)
Other known feature Cross presentation, excel in MHC I
presentation
Excel in MHC II presentation Dudziak et al. (2007), Kamphorst
et al. (2010)
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DC-depleted mice, since LCs are radioresistant. Based on these
results, DEC205+DCs other than LCs (mainly CD8+DEC205+
DCs), have greater regulatory effects on the Foxp3+ T-reg numbers
in the periphery (Fukaya et al., 2012).
IN VIVO ANTIGEN-TARGETING DELIVERY INDUCES
FUNCTIONAL FOXP3+ T-REGS IN TRANSGENIC TCR
Regarding the suppressive function of Foxp3+ T-regs induced by
antigen targeting to DCs in vivo, accumulating evidence has shown
that antigen delivery to the DC subset suppresses experimental
autoimmune encephalomyelitis (EAE) (Hawiger et al., 2004; Stern
et al., 2010; Loschko et al., 2011; Idoyaga et al., 2013). Antigen deliv-
ery to not only DEC205+CD8+ DCs but also Langerin+DCs and
pDCs led to induction of Foxp3+ T regs and suppression of EAE
(Loschko et al., 2011; Idoyaga et al., 2013). Some DEC205+CD8+
DCs express Langerin, and therefore, the targeting antigen to
Langerin+ DCs may represent targeting to DEC205+CD8+ DCs.
While induction of T-regs from Foxp3− cells is reported as the
main mechanism to suppress the autoimmunity via DC antigen
delivery in these reports, it should be noted that in an in vivo pro-
tection assay of EAE, mice require injection with adjuvant CFA,
which could expand Natural T-regs, as described above.
Another notable point is that these in vivo antigen delivery
studies were mainly performed using transgenic mice, and there-
fore, the results may be artificial or specific to the experimental
mice employed. In future immune therapy for autoimmunity,
transplantation tolerance, and allergy, antigen targeting to DCs
in vivo should be undertaken using polyclonal T cell repertoires.
In this regard, it is very intriguing that continuous infusion of
HY male peptide induced antigen-specific Foxp3+ T-regs in the
wild-type naïve repertoire to suppress the male-graft rejection
response (Verginis et al., 2008). Although subcutaneous infusion
of peptide antigen by osmotic pumps was performed (Verginis
et al., 2008) and not targeting antigen to DCs, it is possible that
DEC205+CD8+DCs pick up the infused peptide and present anti-
gen to T cells. Moreover, it is important to ascertain whether
antigen targeting to DCs with the polyclonal T cell repertoire
in humans induces Foxp3+ T-regs. Targeting antigen to DCs via
ASGPR in human induced IL-10 producing T-regs (Li et al., 2012).
Further research on antigen delivery to DCs in vivo with a naïve
repertoire in mice and humans is required.
CD103+DCs ARE SPECIALIZED DCs THAT INDUCE FOXP3+
T-REGS IN THE INTESTINE
It is well established that specialized DC subsets induce Foxp3+ T-
regs in the intestine. The groups of Belkaid and Powrie found that
gut DCs expressing CD103, the αEβ7 integrin, induce Foxp3+ T-
regs using endogenous retinoic acid (RA) and TGF-β (Coombes
et al., 2007; Sun et al., 2007). RA is known to imprint T cells
expressing CD103 with gut-homing instructions (Iwata et al.,
2004). Furthermore, RA, a vitamin A metabolite, controls the
Th17 and Foxp3+ T-reg balance (Mucida et al., 2007). Impor-
tantly, CD103+DCs has retinoic acid dehydrogenase (RALDH)
that activates RA (Coombes et al., 2007; Sun et al., 2007). RA sup-
presses the production of inflammatory cytokines and acts as a
co-factor for TGF-β to induce Foxp3+ T-regs (Hill et al., 2008).
Interestingly, CD103+DCs are migratory DCs that carry anti-
gens from the intestine to lymph nodes (Jaensson et al., 2008).
Therefore, intestine-derived CD103+DCs present feeding antigens
to induce Foxp3+ T-regs and play a key role in maintaining oral
tolerance. The group of Honda showed that Foxp3+ T-regs in
colon are possibly induced by commensal bacteria, Clostridium
(Atarashi et al., 2011). Germ-free mice and antibiotics-treated
mice had decreased numbers of Foxp3+ T-regs in colon, but
increased or unchanged numbers of T-regs in small intestine.
Clostridium-colonized gnotobiotic mice exhibited a robust accu-
mulation of Foxp3+ T-regs in colon, but not in small intestine.
Colonic epithelial cells stimulated with Clostridum produced TGF-
β (Atarashi et al., 2011). Therefore, Foxp3+ T-regs are induced by
Clostridium directly in the colon, but not in the small intestine. It
is possible that Foxp3+ T-reg induction in the small intestine and
colon may be regulated via different mechanisms.
THE ROLE OF VITAMIN D IN INDUCTION OF FOXP3+ T-REGS
BY DC SUBSETS
Another intriguing question to solve was whether vitamin D3
generated skin facilitates Foxp3+ T-reg induction, in view of the
finding that RA, the active metabolite of vitamin A, play a role
in inducing Foxp3+ T-regs in the intestine. Vitamin D3 (chole-
calciferol) is generated in the skin in response to sun exposure,
and converted to active 1,25 (OH)2D3 through an enzymatic cas-
cade in the liver and kidney. Vitamin D controls not only calcium
homeostasis but also the immune functions (Sigmundsdottir and
Butcher, 2008; Baeke et al., 2010; Maruotti and Cantatore, 2010).
Active 1,25 (OH)2D3 production is controlled by 25-
hydroxyvitamin D3-1α-hydroxylase (25(OH)D3-1α-hydroxylase),
the mitochondrial cytochrome P450 enzyme that catalyzes the
conversion of 25(OH)D3. Synthesis of 1,25 (OH)2D3 normally
occurs in the kidney. However, it is reported that DCs partici-
pate in local production of active 1,25 (OH)2D3 in an autocrine
or paracrine manner (Fritsche et al., 2003). In experiments using
human monocyte-derived DCs, they found that LPS-matured DCs
actively produced 1,25 (OH)2D3.
Sigmundsdottir et al. (2007) reported that the sun-light
induced precursor, vitamin D3, is metabolized by DCs and pre-
sented as 1,25 (OH)2D3 to responding T cells. The vitamin,
1,25 (OH)2D3, induced T-cell expression of CCR10 and T-
cell migration to the chemokine, CCL27. Human DCs express
both 25- and 1-hydroxylase activities (CYP27A1 and CYP27B1).
The group demonstrated that monocyte-derived DCs and skin-
draining lymph node DCs have the capacity to activate vita-
min D3. However, the type of DC subset activating vitamin D3
remains unknown and should be an exciting focus of future
research. Mouse T cells upregulate CCR10 and move by chemo-
taxis to CCL27 less efficiently than human T cells after treatment
with 1,25 (OH)2D3 (Sigmundsdottir et al., 2007; Sigmundsdot-
tir and Butcher, 2008). Therefore, identification of the vitamin
D-metabolizing DC subset that plays a role in inducing Foxp3+
T-regs or expanding Natural T-regs using mice may be difficult.
Although the DC subsets metabolizing vitamin D3 have not
been determined, vitamin D clearly play a role in Foxp3+ T-regs
(Ghoreishi et al., 2009; Jeffery et al., 2009; Urry et al., 2012). For
example, Jeffery et al. (2009) reported that human CD25− CD4+
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T cells are converted into CTLA-4+Foxp3+ T-regs in the presence
of mature DCs plus inactive 25(OH)D3. Based on this finding, it
is proposed that mature DCs produce active 1,25 (OH)2D3 and
induce Foxp3+ T-regs from Foxp3− cells. Urry et al. (2012) showed
that human and murine Natural T-regs maintain Foxp3 expres-
sion and are expanded in the presence of active 1,25 (OH)2D3,
even with the absence of DCs in the culture. Therefore, it is pos-
sible that vitamin D play a role in the stimulation of both Natural
T-regs and Induced T-regs.
SKIN DC SUBSETS AND FOXP3+ T-REGS
Dendritic cell subsets are more complex in skin and skin-draining
LNs (Figure 2). Skin-resident DCs include epidermal Langer-
hans cells (LCs) and dermal DCs. Langerin (CD207) is a C-type
lectin mainly expressed on mainly LCs. It was originally assumed
that Langerin+ dermal DCs constitute transit LCs from the epi-
dermis to skin-draining lymph nodes, until a distinct popula-
tion was identified (Bursch et al., 2007; Ginhoux et al., 2007;
Poulin et al., 2007; Nagao et al., 2012). LCs are radioresistant
and renew via in situ proliferation in the steady state (Merad
et al., 2002; Poulin et al., 2007). Some precursors of LCs are
recruited from monocytes to hair follicles after stress (Nagao et al.,
2012). In contrast, Langerin+ and Langerin− dermal DCs are
constantly maintained by blood-borne radiosensitive bone mar-
row precursors (Bursch et al., 2007; Ginhoux et al., 2007; Poulin
et al., 2007; Liu et al., 2009). Furthermore, recent reports indi-
cate that dermal DCs are divided into three subsets: Langerin+
CD11blow, Langerin− CD11b−, and Langerin− CD11b+ (Guil-
liams et al., 2010b; Henri et al., 2010). In these studies, half
of the Langerin+ CD11blow dermal DCs appeared to express
CD103, while the other half were devoid of CD103. Skin DCs
constantly migrate to skin-draining lymph nodes and constitute
migratory DC subsets. Therefore, in skin-draining lymph nodes,
there are resident classical CD8+ DCs, CD8− DCs, pDCs, and
migratory skin DCs, including LCs and three to four dermal
DCs.
Accumulating evidence has shown that lymphoid tissue-
resident CD8+ DCs and CD103+ DCs are members of the same
subset (Ginhoux et al., 2009; Edelson et al., 2010). CD8+ DCs and
CD103+ DCs play specialized roles for cross-presentation (Bedoui
et al., 2009), and their development is regulated by the same four
transcription factors (Belz and Nutt, 2012). Lagnerin+CD103+
DCs are specialized to cross-present antigens (Henri et al., 2010).
Moreover, CD103+ DCs are considered migratory DCs (Huang
et al., 2010). Some resident CD8+DCs are known to express
Langerin (Cheong et al., 2007). Malissen and colleagues pro-
posed that the universal classification of DCs into five major
subsets irrespective of tissues and species, specifically, monocyte-
derived inflammatory DCs, LCs, pDCs, CD11b-type DCs, and
CD8-type DCs (Guilliams et al., 2010b). Among these, CD11b-
type DCs are heterogeneous (Ginhoux et al., 2009). Notably, the
gut CD103+DCs that induce Foxp3+ T-regs may be different from
CD8-type DCs such as dermal Langerin+CD103+DCs because the
gut CD103+DCs express CD11b, whereas Langerin+CD103+DCs
do not (Heath and Carbone, 2009). It is possible that the gut
CD103+ DC subset is one of CD11b-type DCs (Heath and
Carbone, 2009).
According to this classification, migratory CD103+DCs and
resident CD8+DCs are Langerin± and considered part of the same
subset as CD8-type DCs. This theory is attractive since both migra-
tory CD103+DCs and resident CD8+DCs are probably active in
inducing Foxp3+ T-regs (Yamazaki et al., 2008; Idoyaga et al.,
2013). Thus, another possible common feature of CD8-type DC
may be Foxp3+ T-reg induction activity.
In view of the complex skin DC network, cross-talk between
skin DC subsets and Foxp3+ T-regs may be also complex
(Figure 2). Based on the universal classification system, CD103+
Langerin+ CD11blow dermal DCs are apparently CD8-type DCs,
FIGURE 2 |The classification of skin DC subsets. Skin DCs are epidermal
Langerhans cells (LCs) and dermal DCs. Dermal DCs constitute Langerin+ and
Langerin− subtypes. Langerin+ dermal DCs are further subdivided into
CD103+ and CD103− groups. These skin DCs carry antigens and migrate to
draining lymph nodes. Skin-draining lymph nodes contain many DC subsets,
including skin migratory DCs, resident classical CD8+DCs, CD8− DCs, and
pDCs. Therefore, interactions between DC subsets and T-regs in skin and
skin-draining lymph nodes may be complex.
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while CD103− Langerin+ CD11blow dermal DCs and Langerin−
DCs should be CD11b-type DCs. In brief, skin CD103+ dermal
DC subsets are CD8-type DCs. Considering that intestine CD103+
DCs induce Foxp3+ T-regs using RA, the issue of whether skin
CD103+ DCs also activate RA and induce Foxp3+ T-regs was
investigated by a couple of groups. Among the skin DC subsets
investigated for ability to activate RA, dermal-derived CD103−
DCs, and not CD103+ DCs, produced RA and induce Foxp3+
T-regs in the skin-draining LNs (Guilliams et al., 2010a). Simi-
larly, migratory CD11c+MHC classIIhigh DCs, which should con-
tain both CD103+ and CD103− DCs, induced Foxp3+ T-regs
from Foxp3− cells using RALDH (Vitali et al., 2012). Moreover,
Langerin+ dermal DCs, containing CD103+ and CD103− DCs
(Henri et al., 2010), induced Foxp3+ T-regs in the OVA-expressing
keratinocyte system (Azukizawa et al., 2011). Thus, it appears that
migratory dermal DCs including both CD103+ and CD103− DC
population play a role in inducing Foxp3+ T-regs from Foxp3− T
cells in skin (Table 2).
The next issue to resolve was the role of LCs in inducing Foxp3+
T-regs. LCs produce TGF-β (Kaplan et al., 2007; Bobr et al., 2012),
and are suggested to function in maintaining tolerance rather than
inducing immunity (Kaplan et al., 2005; Obhrai et al., 2008; Igyarto
et al., 2009; Bobr et al., 2010; Fukunaga et al., 2010; Yoshiki et al.,
2010; Kautz-Neu et al., 2011; Shklovskaya et al., 2011). Epidermal
RANKL-stimulated LCs expand T-regs in transgenic mice with
RANKL expression under the K14 promoter (Loser et al., 2006).
Importantly, a recent study reported proliferation of human skin
Foxp3+ T-regs with autologous LCs in the culture (Seneschal et al.,
2012). However, in this report, it was unclear whether T-regs were
expanded or induced from Foxp3− T cells, since whole T cells were
used as the starting population. It is a considerable challenge to
distinguish between Natural T-reg expansion and Induced T-reg
induction, because Foxp3 is easily up-regulated in humans (Walker
et al., 2003; Tran et al., 2007), and it is impossible to use the Foxp3-
reporter as in mice. Another recent investigation showed that LCs
protect against allergic contact dermatitis by toleralizing CD8+ T
cells through Foxp3+ T-regs (Gomez de Aguero et al., 2012). In this
study, the conversion of Foxp3+ T-regs from Foxp3− cells did not
occur, suggesting that LCs expand already existing Natural T-regs.
Finally, Langerin+DC-depleted mice lacking LCs and Langrin+
dermal DCs did not develop autoimmune diseases (Bennett et al.,
Table 2 | Skin DC subsets and probable mechanisms to induce Foxp3+
T-regs.
Skin DC subsets Reference
LCs TGF-β production Kaplan et al. (2007),
Bobr et al. (2012)
Langerin− CD103− CD11b+
dermal DCs
RALDH+ Guilliams et al.
(2010a)
MHC class IIhigh CD11c+
migratory DCs (CD103±)
RALDH+ Vitali et al. (2012)
Langerin+ dermal DCs (CD103±) TGF-β production Azukizawa et al.
(2011)
2005; Kaplan et al., 2005; Kissenpfennig et al., 2005), suggesting
that other types of DCs compensate to maintain the Foxp3+ T-reg
population.
POSSIBLE ROLE OF TLR-2 SIGNALING IN INDUCING FOXP3+
T-REGS IN SKIN
As discussed above, skin DCs appear to play a key role in expanding
Natural T-regs and inducing T-regs. It is speculated that Foxp3+
T-regs also function in maintaining the tolerance versus immu-
nity in the skin (Dudda et al., 2008; Tomura et al., 2010; Naik et al.,
2012). Indeed, Foxp3+ T-regs are enriched in skin, compared to
lymphoid tissue (Sather et al., 2007; Naik et al., 2012). It would
therefore be interesting to determine the type of signals controlling
Foxp3+ T-regs in skin. One possibility is TLR signals, since skin
is exposed to many commensals, among which yeast, Staphylococ-
cus and Mycoplasma provide a source of TLR-2 ligands (Yamazaki
et al., 2011). TLR-2 signaling is known to activate Foxp3+ T-reg
induction (Chen et al., 2009; Manicassamy et al., 2009; Round and
Mazmanian, 2010). Zymosan from yeast can bind to TLR-2 and
dectin-1, a C-type lectin, expressed on DCs, and induces TGF-β
(Dillon et al., 2006). Zymosan induces RALDH expression in DCs
via a mechanism largely dependent on TLR2-mediated activation,
which induces Foxp3+ T-regs (Manicassamy et al., 2009). Pam2
lipopeptides, derived from Staphylococcus aureus or Mycoplasma,
are TLR-2 ligands (Yamazaki et al., 2011). Therefore, stimulation
from yeast, Staphylococcus or Mycoplasma may be a trigger for the
induction of Foxp3+ T-regs through TLR-2.
TLR-2 signal induces Foxp3+ T-regs via IL-10 production and
suppresses anti-tumor response to melanoma in mice (Yamazaki
et al., 2011). Other studies have consistently reported that DCs
activated by TLR-2 express RALDH and induce Foxp3 (Manicas-
samy et al., 2009). It is unclear whether TLR-2 signals stimulate
induction of Foxp3+ T-regs from Foxp3- precursor cells or expan-
sion of Natural T-regs, since most investigators used whole CD4+
T cells as starting population. TLR-2 induces RALHD in DCs.
Therefore, it is speculated that TLR-2 signals induce Foxp3+ T-regs
from Foxp3− precursor cells as CD103+DCs from the intestine.
TLR-2 stimulation through commensals may additionally be
required for Foxp3 induction, especially in the skin where yeast,
Staphylococcus, or Mycoplasma always exist. However, a signifi-
cant finding by the group of Belkaid is that the frequency of
Foxp3+ T-regs in skin is more increased in germ-free mice (Naik
et al., 2012). In cases where a skin commensal bacteria, S. epider-
midis, was applied on the skin of germ-free mice, Foxp3+ T-regs
were reduced and IFN-γ producing effector T cells increased in
skin (Naik et al., 2012). The resident commensals in skin appear
to modulate the induction of effector T cells in a Myd88/IL-1-
dependent manner (Naik et al., 2012). Moreover, keratinocytes
from germ-free mice actively produce IL-1 receptor antagonist (IL-
1ra), leading to the suppression of effector T-cell development, and
DC populations are not affected in skin (Naik et al., 2012). Thus, it
appears that Foxp3+ T-reg and effector T cell balance is controlled
directly by commensals in skin. Surprisingly, only a single type of
commensal is sufficient to induce effector T cells and conversely
reduce Foxp3+ T-regs in skin. Further studies are required to clar-
ify whether TLR-2 signaling is required for maintaining Foxp3+
T-regs in skin.
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DCs HAVE A ROLE IN INDUCING OR EXPANDING FOXP3+
T-REGS IN THE ORAL CAVITY
We recently focused on the oral-cavity located between the skin
and intestine, which also contains many commensals. The oral
cavity is often affected by systemic immunological disorders, such
as Stevens–Johnson syndrome and Behçet disease, and exposed to
several antigens, including foods and pathogens, and mechanical
signals via biting. Antigen administration through the oral cavity,
such as sublingual (s.l.) immunotherapy, is employed to treat res-
piratory allergy and allergic rhinitis and conjunctivitis (Moingeon
and Mascarell, 2012; Passalacqua et al., 2013). However, the mech-
anisms by which tolerance versus immunity are regulated in the
oral cavity are unclear at present.
Dendritic cells from the oral cavity are capable of generat-
ing Foxp3+ T-regs, which may maintain tolerance (Figure 3)
(Yamazaki et al., 2012). CD11c+ DCs from oral-cavity-draining
lymph nodes have the capacity to generate Foxp3+ T-regs in the
presence of antigen in vitro (Yamazaki et al., 2012). It is possible
that specialized DC subsets are required to induce Foxp3+ T-regs
in the oral cavity, as CD103+DCs induce Foxp3+ T-regs in the
intestine. No increase in migratory class IIhigh DCs, CD103+ DCs,
CD8+ DCs, and pDCs in the oral-cavity-draining lymph nodes
was observed (Yamazaki et al., 2012). The frequency of CD8− DCs
in oral-cavity-draining lymph nodes was slightly higher than in
axillary lymph nodes (Yamazaki et al., 2012). In view of our former
FIGURE 3 | DCs from the oral-cavity induce Foxp3+ T-regs to maintain
tolerance. The oral cavity is exposed to several antigens and stimuli,
including foods, microbes, inhaled antigens, and mechanical stimulation.
These stimuli may be sensed by DCs that play a role in generating Foxp3+
T-regs to maintain tolerance in the oral cavity.
finding that 33D1+ CD8− DCs expand Natural T-regs (Dudziak
et al., 2007), it is possible that CD8− DCs play a role in expanding
Natural T-regs, rather than inducing Foxp3+ T-regs from Foxp3−
precursors in oral-cavity-draining lymph nodes.
Three distinct subsets of migrating DCs from the oral
mucosa have been identified in the regional lymph nodes
(Chalermsarp and Azuma, 2009), specifically, CD11chigh
Langerin−,CD11cinter/lowLangerin−, and CD11cinter/lowLangerin+,
which are all CD8 negative. It appears that CD11c+CD8− DCs
capture s.l. administered antigen and ferries it into the drain-
ing lymph nodes where both migratory CD8− DCs and resident
CD8+DCs prime the CD4 response (Song et al., 2009). S.l.-
administered protein antigens are captured by DCs and are rapidly
recruited to draining lymph nodes within 12–24 h, and the regu-
latory mechanisms established within 2–5 days in draining lymph
nodes (Passalacqua et al., 2013). Both Foxp3+ T-regs and IL-10
producing Tr1 type T-regs are induced upon s.l. immunization
(Bohle et al., 2007).
Further research is required to establish whether DCs in oral-
cavity-draining lymph nodes induce Foxp3+ T-regs from Foxp3−
precursors or expand existing Foxp3+ T-regs. Additionally, the
mechanisms underlying the maintenance of immune tolerance in
the oral-cavity require clarification.
FOXP3+ T-REGS AND DC SUBSETS IN HUMANS
The majority of studies on Foxp3+ T-regs and DCs described
above were performed using mice. It is quite important to ascer-
tain whether the interactions of Foxp3+ T-regs and DCs are similar
in mice and humans. As we mentioned earlier, a limited number of
studies have been performed in humans showing that epidermal
LCs stimulate the proliferation of Foxp3+ T-regs in the culture
(Seneschal et al., 2012) and IL-10 producing T-reg is induced by
ASGPR DCs in human (Li et al., 2012).
Murine CD8+DEC205+DCs are specialized DCs to induce
Foxp3+ T-regs from Foxp3− T cells (Yamazaki et al., 2008), but
the applicability of these results to humans requires further study.
Four groups simultaneously identified BDCA3(CD141)+ DCs
as the human equivalent of mouse CD8+DCs (Bachem et al.,
2010; Crozat et al., 2010; Jongbloed et al., 2010; Poulin et al.,
2010). In terms of similarities, murine CD8+ DCs and human
BDCA3+ DCs express XCR1, a chemokine receptor (Dorner
et al., 2009; Bachem et al., 2010; Crozat et al., 2010, 2011;
Kroczek and Henn, 2012). Moreover, both murine CD8+ DCs
and human BDCA3+XCR1+DCs are specialized DCs for cross
presentation (Dudziak et al., 2007; Dorner et al., 2009; Jong-
bloed et al., 2010; Poulin et al., 2010; Bachem et al., 2012).
Murine CD8+DCs are tolerogenic DCs in mice (Hawiger et al.,
2001; Bonifaz et al., 2002; Mahnke et al., 2003; Kretschmer et al.,
2005; Yamazaki et al., 2008). A recent study demonstrated that
BDCA3+DCs in skin induce IL-10 and regulatory T cells in
humans (Chu et al., 2012). BDCA3+DCs and Foxp3+ T-regs
are closely located within skin (Chu et al., 2012). Moreover,
BDCA3+DCs induce CD25high CD4+ T cells that suppress the
alloimmune response in vitro and in vivo (Chu et al., 2012).
Therefore, it is possible that BDCA3+DCs in humans have spe-
cialized function in inducing Foxp3+ T-regs, similar to CD8+DCs
in mice.
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Recent experiments showed that the function of Foxp3+ T-
regs is recovered in psoriatic patients after exposure to ultraviolet
(UV) therapy (Furuhashi et al., 2013). Interestingly, Krueger and
colleagues reported increased BDCA3+ DCs in skin biopsy speci-
mens after narrow band UV therapy (Kennedy Crispin et al., 2013),
suggesting that BDCA3+DCs play a key role in Foxp3+ T-reg func-
tion following UV therapy. Further studies are required to examine
human DC and T-reg interactions.
CONCLUSION
We have discussed the roles of DCs in inducing and expand-
ing Foxp3+ T-regs. Induction or expansion of antigen-specific
T-regs using DCs may be provide an effective solution to treat
autoimmune diseases, transplantation tolerance, and allergy. Fur-
ther studies focusing on polyclonal T cell repertoires to gener-
ate antigen-specific Foxp3+ T-regs are warranted, particularly in
humans.
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